FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma – FDA.gov
Business Insider |
FDA approves CAR–T cell therapy to treat adults with certain types of large B-cell lymphoma
FDA.gov The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two … A cancer treatment that's part of 'a big new field of medicine' just got approved FDA follows through with a groundbreaking OK for Yescarta, Gilead's new CAR–T breakthrough FDA approves a game-changing treatment for blood cancer |
